Classification of colon adenocarcinoma based on immunological characterizations: Implications for prognosis and immunotherapy

Accurate immune molecular typing is pivotal for screening out patients with colon adenocarcinoma (COAD) who may benefit from immunotherapy and whose tumor microenvironment (TME) was needed for reprogramming to beneficial immune-mediated responses. However, little is known about the immune characteri...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Midie, Chang, Jinjia, Wang, Wenfeng, Wang, Xin, Wang, Xu, Weng, Weiwei, Tan, Cong, Zhang, Meng, Ni, Shujuan, Wang, Lei, Huang, Zhaohui, Deng, Zhenzhong, Li, Wenhua, Huang, Dan, Sheng, Weiqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363576/
https://www.ncbi.nlm.nih.gov/pubmed/35967414
http://dx.doi.org/10.3389/fimmu.2022.934083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363576/
https://www.ncbi.nlm.nih.gov/pubmed/35967414
http://dx.doi.org/10.3389/fimmu.2022.934083

Ejemplares similares